A novel dual Janus kinase/protein kinase inhibitor alleviates rheumatoid arthritis at higher doses without causing lipid or creatine kinase changes.

Significant data exists to suggest that dual leucine zipper kinase (DLK, MAP3K12) is a conserved regulator of neuronal degeneration following neuronal injury and in chronic neurodegenerative disease.